Solvent/Detergent Treated Human Plasma
Human plasma treated with TNBP/Tween 80 to disrupt lipid envelopes of viruses, then purified. Used for transfusion medicine. Classifies as human blood fraction under HTS 3002.12.00.10 despite viral inactivation processing.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If other antisera/blood fractions not specifically plasma
Subheading distinguishes plasma from other human blood fractions like serum.
If for lab research without therapeutic labeling
Chapter exclusion for diagnostic reagents applies to non-therapeutic plasma.
If in sterile surgical kits
Plasma components in wound closure kits classify under heading 3006(a).
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Include partition validation studies showing lipid removal post-S/D treatment
• Document dual viral inactivation (S/D + heat) to prevent diagnostic reagent confusion
Related Products under HTS 3002.12.00.10
Fresh Frozen Human Plasma
Fresh frozen human plasma is obtained from whole human blood and frozen within 8 hours of collection to preserve clotting factors. It is used therapeutically for patients with coagulopathies or massive transfusion needs. Classified under HTS 3002.12.00.10 as human blood plasma prepared for therapeutic uses.
Cryoprecipitated Antihemophilic Factor from Human Plasma
Cryoprecipitate is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor, prepared by thawing frozen plasma at 1-6°C. It treats hemophilia A and fibrinogen deficiencies. Falls under HTS 3002.12.00.10 as a human blood fraction derived from plasma.
Human Plasma-Derived Immunoglobulin Fraction
IVIG (intravenous immunoglobulin) is a pooled human plasma fraction containing antibodies for immune deficiency treatment. Prepared via cold ethanol fractionation. While purified, retains blood fraction classification under HTS 3002.12.00.10.
Human Plasma for Further Manufacture
Bulk human plasma supplied to fractionators for producing albumin, IVIG, and clotting factors. Prepared with therapeutic end-use in mind. Classified HTS 3002.12.00.10 as blood plasma for therapeutic applications.
Lyophilized Human Plasma for Surgical Use
Lyophilized (freeze-dried) human plasma is dehydrated plasma reconstituted with sterile water for volume replacement in surgery. It provides essential proteins and clotting factors. Classified in HTS 3002.12.00.10 as processed human blood plasma for therapeutic applications.
Pathogen-Reduced Human Plasma
Human plasma treated with amotosalen/UVA light to inactivate viruses, bacteria, and parasites while preserving therapeutic proteins. Used for transfusion in immunocompromised patients. HTS 3002.12.00.10 covers this modified human blood plasma.